Novavax Reaches Five-Month High After Settling COVID Vaccine Dispute
Novavax Reaches Five-Month High After Settling COVID Vaccine Dispute
Share Prices Surge in the Aftermath Novavax shares soared to their highest level in five months following the resolution of a longstanding dispute over vaccine deliveries to the global vaccine alliance Gavi. The Gaithersburg, Maryland-based biotech company reached an agreement with Gavi to pay at least $475 million in cash or vaccines by the end ...












